The Filing Desk

PTC Therapeutics vs Royalty Pharma

PTC Therapeutics PTCT · Royalty Pharma RPRX · Pharmaceuticals

Royalty Pharma reported revenue of $2.4 billion in fiscal 2025, 1.4 times PTC Therapeutics' $1.7 billion in fiscal 2025. PTC Therapeutics' revenue grew 114.5% in its latest year, and Royalty Pharma's grew 5.1%. PTC Therapeutics had an operating margin of 50.1%, against 65.6% at Royalty Pharma.

Side by side

PTC TherapeuticsRoyalty Pharma
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$1.7B$2.4B
Revenue growth114.5%5.1%
Revenue growth a year, last 5 years35.4%2.3%
Gross margin——
Operating margin50.1%65.6%
Net margin39.4%32.4%
Free cash flow$702M—
Free cash flow margin40.6%—
Return on capital—8.9%
Net debt to EBITDA—5.3x
Dividends and buybacks$0M$1.2B
Change in diluted share count14.9%−5.0%
Last close$58.33$67.72
P/E at the last close—44.3×
Insider trades, last 12 monthssold $55.0 millionsold $110.9 million
Piotroski F-score—5 of 8
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
PTC TherapeuticsRoyalty Pharma
Operating margin
Percent of revenue
PTC TherapeuticsRoyalty Pharma
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
PTC TherapeuticsRoyalty Pharma

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the PTC Therapeutics and Royalty Pharma pages.